The Real-World Practice of Fruquintinib for Chinese Patients with Metastatic Colorectal Cancer.
Yan SongTao QuHonggang ZhangYong-Kun SunChengxu CuiYihebali ChiWen ZhangXingyuan WangLin YangPublished in: Cancer management and research (2021)
The outcome of this real-life study was consistent with that of the randomised controlled trial. There were no new safety concerns. Future studies of fruquintinib should be conducted to identify patients who tend to obtain more benefits from fruquintinib alone or in combination with other agents.